Page 8 of 16

PA15.1-3 | Megaloblastic Anaemia — Aetiology, Blood Picture & Diagnostic Framework — Part 2

Bone Marrow Findings in Megaloblastic Anaemia

Three-panel illustration comparing normal bone marrow cells with megaloblastic changes, highlighting nuclear-cytoplasmic asynchrony and giant cell formations characteristic of B12/folate deficiency.

Bone Marrow Findings in Megaloblastic Anaemia

Panel A: Normal normoblasts with condensed nuclei, normal metamyelocytes, typical megakaryocytes. Panel B: Megaloblasts with N:C asynchrony, giant metamyelocytes, hypersegmented megakaryocytes - the MARROW TRIAD. Panel C: Detailed comparison showing mature cytoplasm with immature open-faced nuclei (megaloblasts) versus normal nuclear condensation.

Bone marrow examination is rarely needed for diagnosis today (B12/folate assays are definitive), but the morphology is classic and examination-essential.

Macroscopic (aspirate): Hypercellular marrow — all three lineages expanded but abnormal.

Erythroid lineage — megaloblastic change:
Megaloblasts — erythroid precursors that are larger than normal normoblasts. The defining feature is nuclear-cytoplasmic (N:C) asynchrony: cytoplasm haemoglobinises normally (matures on schedule) but the nucleus remains large, open-faced, and immature (lacy, fine chromatin with visible nucleoli) because DNA synthesis is stalled. Normal normoblasts show the reverse — nucleus condenses ahead of cytoplasm.
• As megaloblasts attempt to divide, their large nuclei fragment → giant bands and metamyelocytes (see myeloid below).

Myeloid lineage:
Giant metamyelocytes and band forms — horseshoe-shaped giant cells; these are the precursors of the hypersegmented neutrophils seen in the peripheral blood. Pathognomonic of megaloblastic haemopoiesis.

Megakaryocytes:
• Hypersegmented, large, multilobulated megakaryocytes — mirror the same DNA synthesis defect.

Summary mnemonic — MARROW TRIAD: Megaloblasts (N:C asynchrony) | Giant metamyelocytes | Hypersegmented megakaryocytes.

Differentiating B12 from Folate Deficiency — The Diagnostic Algorithm

Three-panel diagnostic algorithm showing the step-by-step approach to differentiate B12 from folate deficiency using serum assays and metabolite testing.

Diagnostic Algorithm: Differentiating B12 from Folate Deficiency

Panel A: Diagnostic flowchart starting from megaloblastic anemia, decision points for Step 1 serum testing and Step 2 metabolite testing when results are equivocal. Panel B: Comparison table showing serum B12, serum folate, and RBC folate levels in B12 deficiency versus folate deficiency with specific cutoff values. Panel C: Metabolite assay results showing homocysteine and methylmalonic acid patterns for definitive differentiation when serum levels are inconclusive.

The peripheral smear and bone marrow cannot distinguish B12 from folate deficiency — both produce identical megaloblastic morphology. You need specific assays.

Step 1 — Serum assays:

TestB12 deficiencyFolate deficiency
Serum B12↓ (<200 pg/mL)Normal or ↑
Serum folateNormal↓ (<3 ng/mL)
RBC folateNormal or ↓↓↓ (more reliable than serum folate)

RBC folate reflects folate status over the prior 3 months (lifetime of the RBC) — more stable than serum folate, which fluctuates with a single meal.

Step 2 — Metabolite assays (when serum B12/folate equivocal):

MetaboliteB12 deficiencyFolate deficiency
Methylmalonic acid (MMA)↑↑Normal
Homocysteine↑↑↑↑

Methylmalonic acid (MMA) accumulates specifically when B12 is low — B12 (as adenosylcobalamin) is required to convert methylmalonyl-CoA → succinyl-CoA. Folate has no role in this pathway. An elevated MMA in the right clinical context confirms B12 deficiency even when serum B12 is borderline.

Homocysteine is elevated in BOTH deficiencies (B12 as cofactor for methionine synthase; folate as 5-methyl-THF donor). It is sensitive but not specific for B12.

Decision rule: Raised MMA + raised homocysteine = B12 deficiency. Raised homocysteine alone (MMA normal) = folate deficiency.

Step 3 — Aetiological workup for B12 deficiency:
• Anti-parietal cell antibody, anti-intrinsic factor antibody → pernicious anaemia
• Schilling test (historical) — two-stage oral radiolabelled B12 absorption test; now largely replaced by antibody assays and gastroscopy

Three-panel comparison showing normal bone marrow cells versus megaloblastic changes with nuclear-cytoplasmic asynchrony and giant cell formation.

Bone Marrow Morphology in Megaloblastic Anaemia

Panel A: Normal normoblasts with condensed nuclei, proper N:C ratio, mature cytoplasm. Panel B: Megaloblasts showing nuclear-cytoplasmic asynchrony, open-faced nuclei, lacy chromatin, visible nucleoli. Panel C: Giant metamyelocytes and band forms with fragmented nuclei from failed cell division.
Side-by-side microscopic comparison showing oval-shaped megaloblastic macrocyte versus round non-megaloblastic macrocyte at 100x magnification.

Megaloblastic vs Non-Megaloblastic Macrocytes: Peripheral Smear Comparison

Panel A: Megaloblastic macrocyte with oval morphology, increased MCV >100 fL, characteristic of B12/folate deficiency. Panel B: Non-megaloblastic round macrocyte with preserved circular shape, typical of alcohol-induced or liver disease macrocytosis.

CLINICAL PEARL

The borderline B12 trap: Serum B12 has a wide grey zone (200–300 pg/mL). A patient with neurological symptoms and B12 of 240 pg/mL may have functional deficiency. Always order MMA and homocysteine when serum B12 is equivocal — raised MMA clinches it. Also remember: serum B12 can be falsely normal in myeloproliferative disorders (raised TC I) — another reason to use metabolite assays.

SELF-CHECK

Serum B12 = 185 pg/mL (low), serum folate = 9.2 ng/mL (normal), MMA = 680 nmol/L (raised; normal <270), homocysteine = 38 µmol/L (raised; normal <15). What is the most accurate interpretation?

A. Isolated folate deficiency — homocysteine is raised

B. Combined B12 and folate deficiency

C. B12 deficiency alone — MMA is the discriminating marker

D. Non-megaloblastic macrocytosis — alcohol most likely

Reveal Answer

Answer: C. B12 deficiency alone — MMA is the discriminating marker

Raised MMA with raised homocysteine = B12 deficiency. MMA only rises when B12-dependent adenosylcobalamin is insufficient (methylmalonyl-CoA → succinyl-CoA pathway). Folate has no role here. Serum folate is normal, ruling out folate deficiency. The elevated homocysteine is consistent with B12 deficiency (methionine synthase needs both B12 and 5-methyl-THF). Non-megaloblastic causes do not elevate MMA.

Non-Megaloblastic Macrocytosis — Key Differentiating Features

Six-panel diagram showing different causes of non-megaloblastic macrocytosis including blood smear appearances and underlying mechanisms

Non-Megaloblastic Macrocytosis: Differential Diagnosis and Key Features

Panel A: Non-megaloblastic blood smear showing round macrocytes without hypersegmented neutrophils. Panel B: Chronic alcohol effect showing membrane lipid changes, GGT elevation, and round macrocytes. Panel C: Hypothyroidism with TSH elevation, bradycardia, and associated macrocytosis. Panel D: Liver disease showing acanthocytes, target cells, and increased membrane cholesterol. Panel E: Reticulocytosis demonstrating size comparison between young reticulocytes and mature RBCs. Panel F: MDS bone marrow showing dysplastic features and ring sideroblasts.

When the MCV is raised but smear shows round macrocytes without hypersegmented neutrophils, and B12/folate are normal, consider:

CauseMechanismClue
Alcohol (chronic)Membrane lipid effect; also nutritional folate deficiency coexistsHistory, round macrocytes, GGT ↑, transaminases ↑
Liver disease↑ Membrane cholesterol → acanthocytes + round macrocytesLFTs, target cells, may also have thrombocytopenia
HypothyroidismReduced erythropoietin + altered metabolismTSH ↑, T4 ↓, bradycardia, cold intolerance
ReticulocytosisYoung reticulocytes are 20–30% larger than mature RBCsHigh reticulocyte count; look for haemolysis/haemorrhage
MDSDyserythropoiesis; clonal diseaseDysplastic features in all lineages; ring sideroblasts; BM shows dysplasia

Key distinction: None of the above produce hypersegmented neutrophils or macro-ovalocytes — those are the megaloblastic signature and are absent in non-megaloblastic macrocytosis.

Schilling test (historical note): The two-stage Schilling test used radiolabelled oral B12 to locate the site of B12 malabsorption (gastric/IF problem vs intestinal). Stage 1: B12 alone (low urinary excretion = malabsorption). Stage 2: B12 + IF (corrects if pernicious anaemia). Now largely replaced by anti-IF antibodies, endoscopy, and metabolite assays — but still appears in exam questions.

SELF-CHECK

Which combination of findings is MOST specific for megaloblastic anaemia as opposed to any other cause of macrocytosis?

A. MCV >110 fL with raised serum LDH

B. Oval macrocytes with hypersegmented neutrophils on peripheral smear

C. Pancytopenia with hypercellular bone marrow

D. Raised homocysteine with normal MMA

Reveal Answer

Answer: B. Oval macrocytes with hypersegmented neutrophils on peripheral smear

Oval macrocytes (macro-ovalocytes) + hypersegmented neutrophils is the pathognomonic peripheral smear combination for megaloblastic anaemia. Raised LDH occurs in many haemolytic and ineffective states. Pancytopenia with hypercellular marrow is also seen in megaloblastic anaemia but can occur in other infiltrative marrow conditions. Raised homocysteine with normal MMA points to folate deficiency (a subtype of megaloblastic disease), but the smear findings are the direct diagnostic signature regardless of cause.